Jason is the Vice President of Open Prairie and responsible for the oversight and reporting of all private equity funds and advisory services. He has extensive experience in private equity investments, real estate development, strategic consulting, and financial analysis and reporting. Prior to joining Open Prairie, he was a pharmaceutical sales representative for Eli Lilly and headed several privately held real estate and media ventures. He received a dual BS in Finance and Marketing from Eastern Illinois University and an MBA from the University of Illinois at Urbana Champaign.
Jason is the Open Prairie deal lead for NewLeaf Symbiotics